Signaling pathways
-
BA6363 RTC-5Summary: RTC-5 (TRC-382) is an optimized phenothiazine with anticancer potency. -
BA6364 DuligotuzumabSummary: Duligotuzumab is a humanized IgG-κ monoclonal antibody. -
BA6365 BafisontamabSummary: Bafisontamab (EMB-01) is a bispecific antibody. -
BA6366 FIIN-3Summary: FIIN-3 is an irreversible inhibitor. -
BA6367 JND3229Summary: JND3229 is a reversible inhibitor. -
BA6368 EAI001Summary: EAI001 is a potent selective mutant epidermal growth factor receptor variant inhibitor. -
BA6369 DZD1516Summary: DZD1516 is a potent and selective inhibitor with good blood-brain permeability. -
BA6370 EMI1Summary: EMI1 is a triple mutant and potent inhibitor. -
BA6371 EGFR-IN-69Summary: EGFR-IN-69 is a potent inhibitor. -
BA6372 NRC-2694Summary: NRC-2694 is an epidermal growth factor receptor antagonist with anticancer and antiproliferative activity.
